Survival benefits from follow-up of patients with lung cancer: A systematic review and meta-analysis

Journal of Thoracic Oncology

Volumn 6, Issue 12, 2011, Pages 1993-2004

  Calman, Lynn ^a   Beaver, Kinta ^b   Hind, Daniel ^c   Lorigan, Paul ^d   Roberts, Chris ^e   Lloyd Jones, Myfanwy ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d CHRISTIE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aftercare; Follow up; Lung cancer; Survival; Survivorship

Indexed keywords

CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ASSESSMENT; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDICAL SOCIETY; META ANALYSIS; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW;

EID: 81755161491     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31822b01a1     Document Type: Article

References (57)

1. World Health Organization IAfRoC. World Cancer Report. Lyon, France: IARC Press, 2003.
2. Alberg AJ, Ford JG, Samet JM. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132(Suppl 3):29S-55S. (Pubitemid 47502798)
3. Coleman M, Rachet B, Woods LM, et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004;90:1367-1371.
4. Colice GL, Rubins J, Unger M, American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest 2003;123(Suppl 1):272S-283S. (Pubitemid 36135722)
5. Vainio A, Auvinen A, with members of the Symptom Prevalence Group. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 1996;12:3-10. (Pubitemid 26187518)
6. Cooley ME. Symptoms in adults with lung cancer: a systematic research review. J Pain Symptom Manage 2008;19:137-153.
7. Crino L, Weder W, van Meerbeeck J, et al, On behalf of the ESMO Guidelines Working Group. Early stage and locally advanced (nonmetastatic) non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl 5):v103-v115.
8. Rubins J, Unger M, Colice GL. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:355S-367S. (Pubitemid 47502818)
9. Scottish Intercollegiate Guidelines Network. Management of Patients with Lung Cancer, 80th Ed. Edinburgh: Scottish Intercollegiate Guidelines Network, 2005.
10. National Institute for Health and Clinical Excellence. The Diagnosis and Treatment of Lung Cancer. London: National Institute for Health and Clinical Excellence, 2011.
11. Saunders M, Sculier JP, Ball D, et al. Consensus: the follow-up of the treated patient. Lung Cancer 2003;42(Suppl 1):S17-S19. (Pubitemid 37378182)
12. Sorensen M, Pijls-Johannesma M, Felip E, On behalf of the ESMO Guidelines Working Group. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v120-v125.
13. D'Addario G, Fruh M, Reck M, et al. Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v116-v119.
14. Gilbert S, Reid KR, Lam MY, et al. Who should follow up lung cancer patients after operation? Ann Thorac Surg 2000;69:1696-1700. (Pubitemid 30445508)
15. Smith T. Evidence-based follow-up of lung cancer patients. Semin Oncol 2003;30:361-368. (Pubitemid 36706560)
16. Hopwood P, Stephens RJ, Hopwood P, et al. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000;18:893-903. (Pubitemid 30106622)
17. Cox K, Wilson E. Follow-up for people with cancer: nurse-led services and telephone interventions. J Adv Nurs 2003;43:51-61. (Pubitemid 37356804)
18. Adlard JW, Joseph J, Brammer CV, et al. Open access follow-up for lung cancer: patient and staff satisfaction. Clin Oncol (R Coll Radiol) 2001;13:404-408. (Pubitemid 34071936)
19. Beaver K, Tysver-Robinson D, Campbell M, et al. Comparing hospital and telephone follow-up after treatment for breast cancer: randomized equivalence trial. BMJ 2009;338:a3147.
20. Tierney J, Stewart L, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta analysis. Trials 2007;8:16.
21. Tierney J, Stewart L, Ghersi D, et al. Practical Methods for Incorporating Summary Time-to-Event Data into Meta Analysis (Supplementary Spreadsheet). Available at:http://www.biomedcentral.com/content/supplementary/ 1745-6215-8-16-S1.xls. Accessed June 2, 2011.
22. Rasbond W. ImageJ 1.40g. Available at: http://rsbweb.nih.gov/ij/index. html, 2008. Accessed July 28, 2011.
23. Parmar M, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1988;17:2815-2844.
24. Benamore R, Shepherd FA, Leighl N, et al. Does intensive follow-up alter outcome in patients with advanced lung cancer? J Thorac Oncol 2007;2:273-281. (Pubitemid 47181708)
25. Moore S, Corner J, Haviland J, et al. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ 2002;325:1145-1147. (Pubitemid 35398708)
26. Sugiyama T, Hirose T, Hosaka T, et al. Effectiveness of intensive follow-up after response in patients with small cell lung cancer. Lung Cancer 2008;59:255-261. (Pubitemid 351173413)
27. Younes RN, Gross JL, Deheinzelin D, et al. Follow-up in lung cancer: how often and for what purpose? Chest 1999;115:1494-1499. (Pubitemid 29275635)
28. Virgo KS, McKirgan LW, Caputo MC, et al. Post-treatment management options for patients with lung cancer. Ann Surg 1995;222:700-710. (Pubitemid 26001233)
29. Zieren HU, Muller JM, Petermann D, et al. The effectiveness of standardized follow-up studies after resection of non-small cell bronchial carcinoma. Langenbecks Archiv fur Chirurgie 1994;379:299-306. (Pubitemid 24316990)
30. Westeel V, Choma D, Clement F, et al. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 2000;70:1185-1190.
31. Walsh GL, O'Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995;60:1563-1570; discussion 1570-1572. (Pubitemid 26078243)
32. Review Manager (RevMan) Computer Program, Version 4.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2006.
33. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0. Availble at:http://www.cochranehandbook.org,2008. Accessed July 28, 2011.
34. Fletcher J. What is heterogeneity and is it important? BMJ 2007;334: 94-96. (Pubitemid 46122243)
35. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339: b2700.
36. Ataman OU, Barrett A, Filleron T, et al, ESTRO-REACT Group. Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTRO. Radiother Oncol 2006;78: 95-100. (Pubitemid 43131041)
37. Bell N, Davison V, Peat M. Nurse and physiotherapy led follow-up for lung cancer patients after surgery. Cancer Nurs Pract 2006;5:29-33.
38. McCorkle R, Benoliel JQ, Donaldson G, et al. A randomized clinical trial of home nursing care for lung cancer patients. Cancer 1989;64: 1375-1382. (Pubitemid 19217122)
39. Kim DJ, Lee JG, Lee CY, et al. Long-term survival following pneumonectomy for non-small cell lung cancer: clinical implications for follow-up care. Chest 2007;132:178-184.
40. Nelemans FA, Nelemans FA. Follow-up examinations after operation for lung cancer. Lancet 1973;2:206-207.
41. Motheral B, Brooks J, Clark MA, et al. A checklist for retrospective database studies-report of the ISPOR task force on retrospective databases. Value Health 2003;6:90-97. (Pubitemid 36403125)
42. Aaronson N, Ahmedzai S, Bergman B. The European Organisation for Research and Treatment of Cancer QLQ30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376. (Pubitemid 23073154)
43. Virgo KS, Naunheim KS, McKirgan LW, et al. Cost of patient follow-up after potentially curative lung cancer treatment. J Thorac Cardiovasc Surg 1996;112:356-363. (Pubitemid 26301846)
44. Egermann U, Jaeggi K, Habicht JM, et al. Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J 2002;19:464-468. (Pubitemid 34256960)
45. National Institute of Health and Clinical Excellence. Measuring Effectiveness and Cost Effectiveness: the QALY. Available at:http://www.nice. org.uk/newsroom/features/measingeffectivenessandcost effectivenesstheqaly.jsp, 2008. Accessed July 28, 2011.
46. Pairolero P, Williams D, Bergstrahl E, et al. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984;38:331-336.
47. Sheilds TW, Humphrey E, Higgins GA, et al. Long-term survivors after resection of lung carcinoma. J Thorac Cardiovasc Surg 1978;76:439-445. (Pubitemid 9054045)
48. Egger M, Schneider M, Davey Smith G. Meta-analysis spurious precision? Meta analysis of observational studies. BMJ 1998;316:140-144. (Pubitemid 28121116)
49. Pocock S, Elbourne D. Randomized trials or observational tribulations. N Engl J Med 2000;342:1907-1909.
50. Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001;31:233-240. (Pubitemid 32107019)
51. Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009;10:865-871.
52. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non small-cell lung cancer. N Engl J Med 2010;363:733-742.
53. Aziz NM. Cancer survivorship research: state of knowledge, challenges and opportunities. Acta Oncol 2007;46:417-432. (Pubitemid 46752263)
54. Cox K, Wilson E, Heath L, et al. Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option. Cancer Nurs 2006;29:176-187. (Pubitemid 44309577)
55. Westeel VL. IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer. Rev Mal Respir 2007;24:645-652.
56. van Loon J, Grutters J, Wanders R, et al. Follow-up with 18FDGPET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study. Eur J Cancer 2009;45:588-595.
57. van Loon J, Grutters JP, Wanders R, et al. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. Eur J Cancer 2010;46:110-119.